Processa Pharmaceuticals’ stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises milestone payments and royalties for Processa.
Processa Pharmaceuticals (PCSA) Shares Soar 150% On Gastroparesis Drug Deal
Where Today's News Shapes Tomorrow
